Table 1.
Demographic characteristics of patients and physicians who participated in the alpha testing.
| Patients (n = 8) | Physicians (n = 10) | |
|---|---|---|
| Mean age in years (range) | 42 (35–72) | 45 (36–62) |
| Sex (N, %female) | 6 | 8 |
| Caucasian (N, %) | 8 | 10 |
| Level of education | ||
| High school or less | 2 | |
| Vocational education | 4 | |
| University | 2 | |
| Type of treatment | ||
| Surgery | ||
| Thyroid lobectomy | 2 | |
| Total thyroidectomy | 2 | |
| Systemic therapy | ||
| Lenvatinib | 1 | |
| Sorafenib | 3 | |
| Type of professional (N, %) | ||
| Endocrinologist | 2 | |
| Surgeon | 6 | |
| Oncologist | 2 | |
| Type of hospital (N, %) | ||
| Academic | 4 | |
| Non-academic | 6 | |
| Years of experience as professional (N, %) | ||
| 0–5 years | 3 | |
| 5–10 years | 2 | |
| 10–15 years | 0 | |
| 15–20 years | 3 | |
| >20 years | 2 | |